Vaccine Damage Payment Scheme Under Fire as Nurse Denied Compensation
A nurse who suffered a rare neurological condition after receiving the Oxford-AstraZeneca Covid-19 vaccine has been denied compensation because she is "not disabled enough," reigniting calls for urgent reform of the UK's Vaccine Damage Payment Scheme (VDPS). Marie-Claire Hoyle, 44, developed transverse myelitis—a paralysing inflammation of the spinal cord—two weeks after her second dose in 2020. Her condition was so severe that it triggered a temporary worldwide halt of the vaccine trial. Despite acknowledging that the vaccine caused her injury, the VDPS rejected her claim because her disability no longer meets the 60% threshold required for a £120,000 payout.
Hoyle, a qualified advanced nurse practitioner, says she still suffers from permanent spinal cord damage, nerve pain, and weakness in her hands. "I couldn't hold a pen, I couldn't hold a toothbrush," she said. "I've had an MRI since and there is still damage in my spinal cord, which will never heal." Her case has become a flashpoint in the growing campaign to overhaul a system that critics say fails those with less severe but still life-altering injuries.
Government Commits to Reform After Covid Inquiry Criticism
The government has now committed to reviewing the VDPS following a key recommendation from Baroness Hallett's independent Covid-19 Inquiry. In her fourth report, published last April, Hallett called for "urgent" reform, stating that the current scheme is "not sufficiently supportive" and that the 60% disability threshold "does not work effectively for Covid vaccines." The government says it is committed to ensuring the scheme is "fit for purpose and delivered effectively," but campaigners argue that words must be backed by action.
More than 24,000 Covid-related claims have been made to the VDPS, yet just over 1% have resulted in one-off tax-free awards of £120,000. The scheme, which has been in place since 1979, was designed for a different era of vaccines and has struggled to adapt to the unique challenges posed by the Covid-19 vaccination programme. Baroness Hallett wants payments to be scaled so that those with less debilitating effects can also receive compensation, rather than facing an all-or-nothing threshold.
Marie-Claire Hoyle's Case Highlights Systemic Flaws
Hoyle's experience underscores the human cost of the current system. After volunteering for the AstraZeneca trial in 2020, she was left unable to use her limbs fully. Her condition was so alarming that it led to a temporary worldwide shutdown of the vaccine trial while scientists evaluated the severity of her symptoms. Yet when she applied to the VDPS, she was refused. "They acknowledged that the vaccine caused my transverse myelitis, based on the evidence I supplied with all my medical records, and at the time I was seriously harmed on a value of up to 60%," she said. "However, they said: 'You aren't now, so you don't need the payment.'"
She argues that this logic is fundamentally flawed. "I do still have some pain, some weakness in my hand," she said. "There needs to be a change in that because I do still have some pain, some weakness in my hand." Her call for reform is echoed by campaign groups who say the scheme is out of step with modern medical understanding of vaccine injury, which can include chronic but non-disabling conditions.
Campaigners Demand Clear Commitment, Not Just Review
Vaccine Injured and Bereaved UK, one of the main campaign groups for those harmed by the Covid vaccine, has welcomed the government's acknowledgement that vaccine injury and bereavement are real and that the VDPS is not fit for purpose. However, in a statement, the group said that this is not the same as committing to action. "After more than five years of campaigning, and with the Covid-19 Inquiry explicitly calling for reform as soon as possible, we had hoped the Government would finally come forward with a clear commitment to action, not simply say it would look further at what needs to be done," the group said.
The group stressed that while work may be needed to develop the reforms, there is a real difference between saying you will look at what needs to be done and actually delivering change. They are calling on ministers to set a clear timeline and to engage directly with affected individuals and families in designing a new system.
The Broader Implications: Trust, Compensation, and Public Health
The VDPS reform debate has broader implications for public health policy and trust in vaccination programmes. The scheme was originally established to provide financial support for those injured by vaccines, recognising that while vaccination is a public good, a small number of individuals may suffer serious harm. However, the rigid 60% disability threshold has been criticised as arbitrary and out of date, especially for Covid vaccines where injuries can vary widely in severity and duration.
As the government prepares its response to the Covid Inquiry, the pressure is mounting to create a more flexible, compassionate system. This could include scaled payments based on the severity and permanence of injury, rather than a binary threshold. Such a move would not only provide fairer outcomes for individuals like Hoyle but also help maintain public confidence in vaccination programmes. If people believe that the system will support them if something goes wrong, they may be more willing to participate in future vaccination campaigns.
What Happens Next?
The government has promised to work closely with the devolved nations of the UK as well as those injured by the Covid vaccine and their families. But with no clear timeline for reform, campaigners remain sceptical. The coming months will be crucial in determining whether the VDPS is truly overhauled or whether the promises amount to little more than rhetoric. For Marie-Claire Hoyle and thousands of others, the wait continues—but their calls for justice are growing louder.
Comments